Clinical Trial Update: Mozobil for Autologous Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Mozobil (plerixafor) in autologous hematopoietic stem cell transplantation, enrolling patients with multiple myeloma, Hodgkin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Multiple Myeloma, Hodgkin Lymphoma | Phase 2 | Status: RECRUITING